Buradasınız

Clinical profile of severe plasmodium vivax malaria in a tertiary centre in J.J.M. Medical College, Davangere

Journal Name:

Publication Year:

Abstract (2. Language): 
Background: Malaria continues to be a major public health problem in South East Asia. . Plasmodium vivax is the most widely distributed human malaria parasite with an at-risk population of 2.5 billion persons. With the implementation of molecular diagnosis, it has become evident that P.vivax monoinfect ion could also result in multiple organ dysfunction and severe life-threatening disease as seen in P. Falciparum infection. Materials and Methods: A prospective study was conducted over a period of one and half years on 100 patients with severe malaria infected either with p.vivax or p.falciparum admitted in J.J.M Medical college , Davangere . Observation and Results: Out of 100 patients with severe malaria of which 65(65%) patients had severe vivax and 35(35%) patients had severe falciparum malaria. Amongst vivax group, 43 (66.15%) were males and 22(33.84%) females. Thrombocytopenia (89.23%) was the most common complicat ion followed by hepatic (29.23), renal (7.69%) cerebral (4.61%) and pulmonary (3.07%) involvement. Most patients were in the age group of 21-30 years .The mortality observed in severe vivax malaria was 1.53% (1/65), as compared to falciparum malaria where it was 5.71% (2/35). Conclusion: Severe malaria is usually caused by P. Falciparum but it has been observed in our study that P.vivax malaria, which was considered to be a benign malaria, can also result in severe disease. Thrombocytopenia is very common in severe vivax infection. Also, renal, hepatic, lung and cerebral involvement are also affected.
133
139

REFERENCES

References: 

1. Nicholas J.White. Malaria in Manson’s Tropical Diseases 22nd edition. London: WBSaunders
Co; 2009: 1201-1281.
2. White NJ, Bregman JG. Malaria. In: Braunwald, Kasper, Hauser, Lango, Jameson,
Loscalzo,editors, Harrisons principles of internal medicine .17
th
ed . New york : McGraw-Hill
companies 2008 ;1:1280-94.
3. Mohapatra MK. The Natural history of complicated falciparum malaria-A prospective study. JAPI
2006 November;54:848-52.
4. Prakash PS, Madhu Muddaiah. A study of clinical profile of malaria in a referral centre in south
canara . J vect Borne dis 2006 March;43:29-33.
5. Mohapatra MK , Sethi G,Das SP, Patnaikk SR . Incidence ,outcome and predictive factors of
falciparaum malaria with multiorgan failure. JAPI 2001;49:149-50.
6. Nand N, Agarwal H, Sharma M, Singh M .Systemic manifestations of malaria. J Indian Academy
of Clinical Medicine 2001 ;2:189-94.
7. Kochar DK , Kochar SK , Agarwal RP .The changing spectrum of severe falciparum malaria:
clinical study from bikaner(north west India). J Vect Borne Dis 2006 ;31(9):2278 84.
8. Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S,et al. Severe
Plasmodium vivax malaria: a report on serial cases from Bikaner in northwesternIndia. Am J Trop
Med Hyg 2009; 80: 194-8.
9 Milind Y Nadkar, Abhinay M Huchche, Raminder Singh, Amar R Pazare. Clinical Profile of
Severe Plasmodium vivax Malaria in a Tertiary Care Centre in Mumbai from June 2010-January
2011.JAPI October 2012.Volume-60.
10. Wongsrichanalai C, Barcus MJ, Muth S, Sutamihardja A, Wernsdorfer WH. A
review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT).Am J Trop Med
Hyg 2007; 77: 119-27.
11. Murthy GL,Sahay RK,Srinivasan VR,Upadhaya AC,Shantaram V, Gayathri K.Clinical profile of
falciparum malaria in a tertiary care hospital.JIMA April 2000;98(4):160-62.
12. Talib VH ,Hajira BD, Diwan VM, Verma MC .A clinico –haematological profile of malaria .JAPI
1982;30(6):402-404.
13. Charulata S Limaye, Vikram A Londhey, ST Nabar. The Study of Complicationof Vivax Malaria
inComparison with Falciparum Malaria in Mumbai .JAPI October 2012.Volume-60.
14. Mohapatra MK. The Natural history of complicated falciparum malaria-A prospective study. JAPI
2006 November;54:848-52.

Thank you for copying data from http://www.arastirmax.com